PROVIDER PROFILE · NPI 1780684902

Estela OgisteMD, PHD

OphthalmologyNorth Adams, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

4,161

Unique beneficiaries

—

Total services

5,018

Distinct HCPCS

Medicare payment

$370K

Peer benchmark

Total Medicare services vs. 558 Ophthalmology providers in MA — top quintile (cohort median 1,976).

PRESCRIBING · PART D · 2024

Total Rx claims

2,255

Beneficiaries

—

Total drug cost

$352K

Distinct drugs

Brand share

32.7%

Top prescribed drugs

Latanoprost533 claims

Ketorolac Tromethamine336 claims

Prednisolone Acetate241 claims

Timolol Maleate156 claims

Cyclosporine155 claims

QUALITY · MIPS · 2024

Final MIPS score

97.8

Quality

100.0

Cost

87.3

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.96%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$250

Payment records

By payment type

Food and Beverage$250

Top paying entities

Food and Beverage$250

REFERRAL NETWORK

Where Estela Ogiste's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Ambulatory Surgery Center Of Greater New York, Llc Ambulatory Surgical Center · Bronx, NY	29	162
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	23	108
Alan Zimbard Anesthesiology · Bronx, NY	17	87
ST LUKES ROOSEVELT HOSPITAL CENTER	11	51

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history